Scott F Huntington

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Newly Diagnosed

Tyrosine Kinase

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Scott F Huntington, Enrico de Nigris, Justin T Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric M Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A Doshi
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer medicine 13 (2) (2024)
Scott F Huntington, Enrico de Nigris, Justin T Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric M Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A Doshi
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer medicine 13 (2) (2024)
Mengyang Di, Kunal C Potnis, Jessica B Long, Iris Isufi, Francine Foss, Stuart Seropian, Cary P Gross, Scott F Huntington
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI cancer spectrum 8 (4) (2024)
Mengyang Di, Kunal C Potnis, Jessica B Long, Iris Isufi, Francine Foss, Stuart Seropian, Cary P Gross, Scott F Huntington
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas. JNCI cancer spectrum 8 (4) (2024)
Scott F Huntington, Enrico de Nigris, Justin T Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric M Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A Doshi
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer medicine 13 (2) (2024)
Scott F Huntington, Enrico de Nigris, Justin T Puckett, Sachin Kamal-Bahl, Mohammed Farooqui, Katherine Ryland, Eric M Sarpong, Siyang Leng, Xiaoqin Yang, Jalpa A Doshi
Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer medicine 13 (2) (2024)
Kunal C Potnis, Scott F Huntington
Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for R/R follicular lymphoma. Blood advances (2023)
Jackson T Bowers, Jacob L Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Messmer, Joseph Dan Khoa Nguyen, Emily C Ayers, Charlotte B Wagner, Boyu Hu, Mengyang Di, Scott F Huntington, Fateeha Furqan, Nirav N Shah, Christina Chen, Hatcher J Ballard, Mitchell E Hughes, Elise A Chong, Sunita D Nasta, Stefan K Barta, Daniel J Landsburg, Jakub Svoboda
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood advances (2023)
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: an open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Nikolai A Podoltsev, Rong Wang, Rory Michael Shallis, Jessica M Stempel, Mengyang Di, Natalia Neparidze, Amer M Zeidan, Scott F Huntington, Smith Giri, Sarah C Hull, Steven D Gore, Xiaomei Ma
Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia. Cancer medicine (2023)
Mahek Garg, Justin T Puckett, Sachin Kamal-Bahl, Monika Raut, Katherine Elizabeth Ryland, Jalpa A Doshi, Scott F Huntington
Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma. Future oncology (London, England) (2023)
Rory Michael Shallis, Rong Wang, Amer M Zeidan, Scott F Huntington, Natalia Neparidze, Jessica M Stempel, Lourdes M Mendez, Mengyang Di, Xiaomei Ma, Nikolai A Podoltsev
Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence. Blood advances (2023)
Rong Wang, Rory Michael Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan, Steven D Gore, Xiaomei Ma, Nikolai A Podoltsev
Second Malignancies among Older Patients with Classical Myeloproliferative Neoplasms Treated with Hydroxyurea. Blood advances (2022)
Sachin Kamal-Bahl, Justin T Puckett, Indranil Bagchi, Ellen Miller-Sonet, Scott F Huntington
Barriers and solutions to improve access for chimeric antigen receptor therapies. Immunotherapy (2022)
Mengyang Di, Can Cui, Shalin K Kothari, Amer M Zeidan, Nikolai A Podoltsev, Natalia Neparidze, Rory Michael Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington
Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis. Blood advances 6 (11) (2022)
Kunal C Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E Seropian, Francine M Foss, Howard P Forman, Scott F Huntington
Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Adults with Relapsed or Refractory Follicular Lymphoma. Blood advances (2022)
Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory Michael Shallis, Nikolai A Podoltsev, Scott F Huntington, Amer M Zeidan
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia. Blood 139 (11) (2022)
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A Podoltsev, Rory Michael Shallis, Scott F Huntington, Natalia Neparidze, Rong Wang, Amer M Zeidan, Amy J Davidoff
Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia in the United States. Blood advances (2021)
Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C Thompson, Nicole Lamanna, Alexander R Coltoff, Matthew S Davids, Peter O Baker, Lori Leslie, Kerry A Rogers, John N Allan, Raul Cordoba, Alberto López-García, Darko Antic, John M Pagel, Nicolás Martinez-Calle, Jose Antonio Garcia-Marco, Jose-Ángel Hernández-Rivas, Fatima Miras, Catherine C Coombs, Anders Österborg, Lotta Hansson, Amanda N Seddon, Javier López Jiménez, Matthew R Wilson, Dima El-Sharkawi, Daniel Wojenski, Shuo Ma, Talha Munir, Susana Valenciano, Erlene Seymour, Paul M Barr, Jeffrey J Pu, Piers E M Patten, Guilherme F Perini, Scott F Huntington, Helen M Parry, Suchitra Sundaram, Alan Skarbnik, Manali Kamdar, Ryan Jacobs, Harriet Sarah Walter, Renata Walewska, Angus Broom, Sonia Lebowitz, Krista M Isaac, Craig A Portell, Inhye E Ahn, Chaitra S Ujjani, Mazyar Shadman, Sigrid S Skånland, Elise A Chong, Anthony R Mato
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood 138 (18) (2021)
Jan Philipp Bewersdorf, Kishan K Patel, Scott F Huntington, Amer M Zeidan
Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia. Blood advances 5 (22) (2021)
Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M Barlow, Mary-Kate Malecek, Marcus P Watkins, Brad S Kahl, Michael A Spinner, Ranjana Advani, Timothy J Voorhees, Anson Snow, Natalie Sophia Grover, Amy A Ayers, Jason T Romancik, Yuxin Liu, Scott F Huntington, Julio C Chavez, Hayder Saeed, Aleksander Lazaryan, Vikram Raghunathan, Stephen E Spurgeon, Thomas A Ollila, Christopher Del Prete, Adam Olszewski, Emily C Ayers, Daniel J Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F Caimi, Timothy Fu, Jieqi Liu, Kevin A David, Hanan Alharthy, Jennie Y Law, Reem Karmali, Harsh R Shah, Deborah M Stephens, Ajay Major, Alexandra E Rojek, Sonali M Smith, Amulya Yellala, Avyakta Kallam, Shazia Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brain T Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey M Switchenko, Jonathon B Cohen, Craig A Portell
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood (2021)
Kishan K Patel, Smith Giri, Terri L Parker, Noffar Bar, Natalia Neparidze, Scott F Huntington
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Mengyang Di, Scott F Huntington, Adam J Olszewski
Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients. The oncologist 26 (2) (2020)
Amer M Zeidan, Nikolai A Podoltsev, Xiaoyi Wang, Jan Philipp Bewersdorf, Rory M Shallis, Scott F Huntington, Steven D Gore, Amy J Davidoff, Xiaomei Ma, Rong Wang
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis. Cancer 125 (23) (2019)
Scott F Huntington, Weiwei Zhu, Jessica R Hoag, Rong Wang, Amer M Zeidan, Smith Giri, Nikolai A Podoltsev, Steven D Gore, Xiaomei Ma, Cary P Gross, Amy J Davidoff
Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma. JNCI cancer spectrum 3 (2) (2019)
Smith Giri, Weiwei Zhu, Rong Wang, Amer Zeidan, Nikolai Podoltsev, Steven D Gore, Natalia Neparidze, Xiaomei Ma, Cary P Gross, Amy J Davidoff, Scott F Huntington
Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States. Cancer 125 (22) (2019)
Amer M Zeidan, Maximilian Stahl, Xin Hu, Rong Wang, Scott F Huntington, Nikolai A Podoltsev, Steven D Gore, Xiaomei Ma, Amy J Davidoff
Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation. Blood 131 (7) (2017)
Lucy Hui, Gottfried von Keudell, Rong Wang, Amer M Zeidan, Steven D Gore, Xiaomei Ma, Amy J Davidoff, Scott F Huntington
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation. Cancer 123 (19) (2017)
Amer M Zeidan, Xin Hu, Jessica B Long, Rong Wang, Xiaomei Ma, Nikolai A Podoltsev, Scott F Huntington, Steven D Gore, Amy J Davidoff
Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study. Cancer 123 (19) (2017)